We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 9,170 results
  1. Neurofibromatosis type 1 with three synchronous tumors

    Neurofibromatosis type 1, resulting from dominantly inherited mutations affecting neurofibromin, is among the most common human genetic syndromes...

    Shanavas Kakkat, George Sarin Zacharia, ... Anu Jacob in Journal of Rare Diseases
    Article Open access 05 February 2024
  2. Robotic resection for splenic artery aneurysm associated with neurofibromatosis type 1: a case report

    Background

    Neurofibromatosis type 1 is an autosomal-dominant disease characterized by café-au-lait spots and neurofibromas, as well as various other...

    Akihiko Ueda, Kenta Saito, ... Shuji Takiguchi in Journal of Medical Case Reports
    Article Open access 14 March 2024
  3. Giant sacral schwannoma in a neurofibromatosis type 2 patient

    Background

    Neurofibromatosis type 2 is an autosomal dominant disorder, mainly characterized by multiple neurological lesions, such as schwannomas,...

    Namdev Seth, Dushyant Varshney, Saumya Verma in Egyptian Journal of Radiology and Nuclear Medicine
    Article Open access 21 July 2023
  4. Pathological Hip Dislocation in a Neurofibromatosis Patient Secondary to Capsular Hemangioma

    Neurofibromatosis is an autosomal-dominant multi-system disease affecting the nervous, integumentary, ocular, and musculoskeletal systems. In the...

    Badaruddin Sahito, Muhammad Waqas Khan, ... Maratib Ali in Indian Journal of Orthopaedics
    Article 02 May 2024
  5. Risk factors for intraoperative hemorrhage of Type I neurofibromatosis

    Introduction

    Neurofibromatosis (NF) is an inherited disease and a benign tumor originating from nerve sheath cells. Neurofibromatosis type I (NF1) is...

    Qianqian Gao, Siwei Qu, ... Yangqun Li in BMC Surgery
    Article Open access 10 June 2023
  6. Multidisciplinary neurofibromatosis conference in the management of patients with neurofibromatosis type 1 and schwannomatosis in a single tertiary care institution

    Objective

    To evaluate the role of weekly neurofibromatosis (NF) multi-disciplinary conferences (MDC) on the diagnostic and therapeutic plan for...

    Patrick Debs, Allan Belzberg, ... Shivani Ahlawat in Skeletal Radiology
    Article 11 November 2023
  7. Giant gluteal and vesical plexiform neurofibromas in a patient with neurofibromatosis type 1: a case report

    Background

    Neurofibromatosis type 1 is a neurocutaneous genetic disorder caused by mutations in the NF1 gene, resulting in the formation of benign...

    Imen Sassi, Mohamed Amine Bouida, ... Tarek Ben Dhieb in Journal of Medical Case Reports
    Article Open access 13 January 2024
  8. Burden of adult neurofibromatosis 1 questionnaire: translation and psychometric properties of the Persian version

    Background

    The notion of “burden” has taken a key place in the evaluation of care, particularly in the case of rare diseases. The aim of this study...

    Reza Jahanshahi, Zahra Yasaghi, ... Samira Foji in Orphanet Journal of Rare Diseases
    Article Open access 23 June 2023
  9. When Neurofibromatosis Meets Diabetes: A Long-Term Follow-up in a Pediatric Case Report

    Few neurofibromatosis cases described so far in the pediatric population shed light on the rare association between neurofibromatosis and diabetes...

    Article 13 February 2023
  10. Inflammatory rhabdomyoblastic tumor, pheochromocytoma, and pulmonary hamartoma in a patient with neurofibromatosis type 1: a case report

    Background

    Inflammatory rhabdomyoblastic tumors are relatively recently recognized soft tissue tumors with a low malignant potential. Here, we present...

    Otto Jokelainen, Heidi Myllykangas, ... Reijo Sironen in Diagnostic Pathology
    Article Open access 11 June 2024
  11. Management of Central and Peripheral Nervous System Tumors in Patients with Neurofibromatosis

    Abstract

    Neurofibromatosis type I (NF1), neurofibromatosis type 2 (NF2), and schwannomatosis represent a diverse group of genetic tumor predisposition...

    Rebecca Brown in Current Oncology Reports
    Article 31 October 2023
  12. Neurofibromatosis type1, type 2, tuberous sclerosis and Von Hippel-Lindau disease

    Neurocutaneous syndromes (also known as phakomatoses) are heterogenous group of disorders that involve derivatives of the neuroectoderm. Each disease...

    M. Elbeltagy, M. Abbassy in Child's Nervous System
    Article 11 October 2023
  13. Incidence of tethered cord syndrome in neurofibromatosis types 1 and 2 pediatric patients: a population-level analysis

    Purpose

    Tethered spinal cord syndrome (TCS) is characterized by cutaneous attachments on the filum terminale that stretch the spinal cord, leading to...

    Debarati Bhanja, Zachary Freedman, ... Elias Rizk in Child's Nervous System
    Article 07 March 2024
  14. Neurofibromatosis type 1 with huge intrathoracic meningoceles misdiagnosed as pleural effusion: A case report and literature review

    Background

    Neurofibromatosis type 1 is a genetic disease that affects multiple organs and systems, leading to various clinical manifestations. In...

    Ningyi Chen, Wenjuan Li, ... Jiarong Bian in Journal of Cardiothoracic Surgery
    Article Open access 30 May 2024
  15. Pain Related Quality of Life in Neurofibromatosis Type 1: A Narrative Review

    Purpose of Review

    : The purpose of this narrative review is to summarize pain symptomatology and mechanisms in neurofibromatosis type 1 (NF1), discuss...

    Karina Stech, Behnum Habibi in Current Pain and Headache Reports
    Article 27 June 2024
  16. Inflammatory/juvenile-like polyps in neurofibromatosis type 1 associated with epithelial dysplasia

    The term “juvenile-like (inflammatory/hyperplastic) mucosal polyps” (JLIHMP) has been recently introduced to describe a spectrum of polypoid lesions...

    Diana Enea, Xavier Dray, ... Magali Svrcek in Virchows Archiv
    Article 24 February 2024
  17. Gene Therapy for Neurofibromatosis Type 2-Related Schwannomatosis: Recent Progress, Challenges, and Future Directions

    Neurofibromatosis type 2 ( NF2 )-related schwannomatosis is a rare autosomal dominant monogenic disorder caused by mutations in the NF2 gene. The...

    Ruofei Yuan, Bo Wang, ... Pinan Liu in Oncology and Therapy
    Article Open access 17 May 2024
  18. Minimal clinically important difference in the World Health Organization Quality of Life Brief (WHOQOL-BREF) for adults with neurofibromatosis

    Purpose

    This study aimed to estimate minimal clinically important difference (MCID) values for the World Health Organization Quality of Life Brief...

    Malvina O. Pietrzykowski, Ana-Maria Vranceanu, ... Ryan A. Mace in Quality of Life Research
    Article 12 January 2024
  19. Case of embryonal tumor multilayered rosettes in a patient with neurofibromatosis type 1

    Background

    ETMR is a unique and highly malignant brain tumor mostly occurring in infants. This report provides a comprehensive overview of the...

    Soha Zahid, Farrah Bashir, ... Naureen Mushtaq in Child's Nervous System
    Article 07 May 2024
  20. Diagnosis of neonatal neurofibromatosis type 1: a case report and review of the literature

    Background

    Neurofibromatosis Type 1 (NF1) is a rare genetic disorder characterized with the development of multiple benign tumors on the nerves and...

    Qiuying Zheng, Bei **a, ... Lei Liu in BMC Pediatrics
    Article Open access 24 May 2023
Did you find what you were looking for? Share feedback.